Metagenomi Therapeutics (MGX) Liabilities and Shareholders Equity (2023 - 2026)
Metagenomi Therapeutics (MGX) reported Liabilities and Shareholders Equity of $173.7 million for Q2 2026, down 36.2% from $272.28 million a year earlier and down 11.8% from the prior quarter.
Powered by 
Analysis
Metagenomi Therapeutics (MGX) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends
At the end of FY2025, Metagenomi Therapeutics posted Liabilities and Shareholders Equity of $221.1 million, down 31.9% from FY2024.
- By year, Liabilities and Shareholders Equity came in at $324.6 million in FY2024 (-11.0%) and $364.84 million in FY2023.
- The Q2 2026 figure ranks as the lowest quarterly Liabilities and Shareholders Equity in data going back to Q4 2023.
- Year over year, Liabilities and Shareholders Equity has now declined in each of the last seven quarters, with an average decline of 28.8% over the last seven quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $196.95 million (Q1 2026), $221.1 million (Q4 2025) and $247.94 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Metagenomi Therapeutics | 40.04 Mn | 40.04 Mn | - | 173.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 173.70 Mn |
| Mar 31, 2026 | 196.95 Mn |
| Dec 31, 2025 | 221.10 Mn |
| Sep 30, 2025 | 247.94 Mn |
| Jun 30, 2025 | 272.28 Mn |
| Mar 31, 2025 | 297.87 Mn |
| Dec 31, 2024 | 324.60 Mn |
| Sep 30, 2024 | 358.35 Mn |
| Jun 30, 2024 | 385.91 Mn |
| Mar 31, 2024 | 415.40 Mn |
| Dec 31, 2023 | 364.84 Mn |
API Access
Metagenomi Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=MGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "MGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=MGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();